​

NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

NRx Pharmaceuticals Ownership Summary

NRx Pharmaceuticals is owned by 0.03% institutional investors, and 99.97% retail investors. AdvisorShares Psychedelics ETF is the top mutual fund, with 2.43% of its assets in NRx Pharmaceuticals shares.

NRXP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNRx Pharmaceuticals0.03%-99.97%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20215-8,644-38.23%-1513.97%3-25.00%2100.00%
Dec 31, 20205-13,994-94.43%-7.59%4100.00%1-50.00%
Sep 30, 20205-251,366-40.63%-48.05%2-2-33.33%
Jun 30, 20205-16.67%423,407-37.08%132.04%--100.00%3-
Mar 31, 20206-50.00%672,939-73.35%13.62%350.00%350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
AdvisorShares Psychedelics ETF261.27K2.43%-
Vanguard Total Stock Mkt Idx Inv193.42K1.80%-
Fidelity Extended Market Index44.49K0.41%2.02K
Vanguard Institutional Extnd Mkt Idx Tr46.89K0.41%-
Fidelity Series Total Market Index10.33K0.10%4.23K
Fidelity Total Market Index10.01K0.09%-
Spartan Extended Market Index Pool E6.34K0.06%6.34K
BlackRock Extended Equity Market K5.08K0.05%-2.00
Schwab Total Stock Market Index4.37K0.04%-
Northern Trust Extended Eq Market Idx3.82K0.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 17, 2024Javitt Jonathan C Chairman and Chief ScientistBuy$46.80K
Aug 30, 2023Gorovitz Aaron-Buy$11.20K
Aug 30, 2023Hurvitz Chaim-Buy$20.13K
Aug 23, 2023Javitt Jonathan C Chief ScientistBuy$33.00K
Aug 22, 2023Javitt Jonathan C Chief ScientistBuy$64.40K

Insider Transactions Trends

DateBuySell
2024 Q41-
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q34-

NRXP Ownership FAQ

Who Owns NRx Pharmaceuticals?

NRx Pharmaceuticals shareholders are primarily institutional investors at 0.03%, followed by 0% insiders and 0% retail investors. The average institutional ownership in NRx Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which NRx Pharmaceuticals falls below.

Does Blackrock own NRx Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of NRx Pharmaceuticals.

Who is the top mutual fund holder of NRx Pharmaceuticals shares?

AdvisorShares Psychedelics ETF is the top mutual fund holder of NRx Pharmaceuticals shares, with 2.43% of its total shares outstanding invested in 261.27K NRx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools